Core Viewpoint - The stock of Meihao Medical (301363) has experienced a decline, with a closing price of 26.06 yuan on September 12, 2025, down by 1.88% [1] Group 1: Stock Performance and Trading Data - On September 12, 2025, the stock had a turnover rate of 6.82%, with a trading volume of 106,500 hands and a transaction amount of 278 million yuan [1] - The net inflow of main funds was 31.17 million yuan, accounting for 7.33% of the total transaction amount, while retail investors saw a net outflow of 10.76 million yuan, representing 2.53% of the total [1] - Over the past five days, the stock has shown fluctuating performance, with a notable increase in main fund inflow on September 10, 2025, amounting to 33.34 million yuan, which was a 6.98% increase in stock price [2] Group 2: Financial Metrics and Industry Comparison - Meihao Medical's total market value is 14.995 billion yuan, with a net asset of 3.595 billion yuan and a net profit of 114 million yuan, ranking 23rd, 42nd, and 40th respectively in the medical device industry [3] - The company's revenue for the first half of 2025 was 733 million yuan, a year-on-year increase of 3.73%, while the net profit decreased by 32.44% to 114 million yuan [3] - The gross profit margin stands at 37.52%, significantly lower than the industry average of 51.85%, indicating potential challenges in profitability [3] Group 3: Analyst Ratings and Market Sentiment - In the last 90 days, 17 institutions have rated the stock, with 15 buy ratings and 2 hold ratings, suggesting a generally positive outlook among analysts [4] - The average target price set by institutions over the past 90 days is 26.48 yuan, indicating a slight upside potential from the current trading price [4]
股票行情快报：美好医疗（301363）9月12日主力资金净买入3117.42万元